Representatives from Stanford University, Singularity University, the Texas Heart Institute, Washington University in St. Louis, and investors from Silicon Valley and elsewhere have come together to create The Palo Alto Longevity Prize - a $1 million life science competition dedicated to ending aging and promoting the extension of a sustained and healthy lifespan.

The focuses of the Prize are twofold. The first is on studying and altering heart rate variability (HRV), which is the measure of the change in time from one heartbeat to the next. Instead of looking at a person’s average heartbeat HRV monitors performance by measuring how a person's heart reacts to stress or injury.